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M. tuberculosisa major public health problem, especially in low-resource countries where the
burden of the disease is more important. Multidrug-resistant and extensively drug drug-resistant
tuberculosis constitute serious problems for the efﬁcient control of the disease stressing the need to
investigate resistance to ﬁrst- and second-line drugs. Conventional methods for detecting drug-resistance in
Mycobacterium tuberculosis are slow and cumbersome. The most commonly used proportion method on
Löwenstein–Jensen medium or Middlebrook agar requires a minimum of 3–4 weeks to produce results.
Several new approaches have been proposed in the last years for the rapid and timely detection of drug-
resistance in tuberculosis. This review will address phenotypic culture-based methods for rapid drug
susceptibility testing in M. tuberculosis.
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Tuberculosis (TB) represents a major public health problem,
especially in low-resource countries where the burden of the disease
is more important. According to estimates of the World Health
Organisation (WHO), two billion people, roughly one third of thehods for drug-resistance detection in Mycobacterium tuberculosis, J.
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losis the causative agent of the disease. In 2005 there were 8.9 million
new cases of TB and 1.6 million deaths were attributed to the disease
(World Health Organization, 2007a,b). This scenario is aggravated by
the human immunodeﬁciency virus (HIV) pandemic with roughly one
third of the 40 million people currently infected with HIV also co-
infected with TB (Friedland et al., 2007). Multidrug-resistant (MDR)-
TB patients, those harbouring strains of M. tuberculosis resistant to at
least rifampicin (RIF) and isoniazid (INH), two essential drugs in the
treatment of TB, constitute a serious problem for the efﬁcient control
of the disease.
The latest report on anti-tuberculosis drug-resistance in the world
prepared by the WHO/IUATLD Global Project on anti-tuberculosis
drug-resistance surveillance, shows that MDR-TB has reached levels of
up to 14% amongst new patients and rates as high as 50% in
previously-treated patients in some settings (World Health Organiza-
tion, 2004). In addition, the recent description of XDR strains, standing
for ‘extensively drug drug-resistant’ stresses the need to also
investigate resistance to second-line drugs. XDR-TB is deﬁned as
resistance to at least INH and RIF, in addition to resistance to any
ﬂuoroquinolone and to at least one of the three injectable drugs used
in the treatment of TB: capreomycin, kanamycin and amikacin (World
Health Organization, 2006). Thus, early detection of drug-resistance to
ﬁrst- and second-line drugs in M. tuberculosis represents a major
priority for TB control programmes.
Conventional methods for detecting drug-resistance in M. tuber-
culosis are slow and cumbersome. Laboratory diagnosis is further
complicated by the fastidious growth of the tubercle bacillus. For TB
diagnostics laboratories in high-burden countries, primary isolation is
the ﬁrst step before performing drug susceptibility testing (DST) ofM.
tuberculosis. The traditionally accepted methods include the propor-
tion method, the absolute concentration method, the resistance ratio
method and the radiometric BACTEC TB-460 system (Becton Dick-
inson, Sparks, MD) (Canetti et al., 1969; Kent and Kubica, 1985; Heifets
and Cangelosi,1999). The most commonly used proportionmethod on
Löwenstein–Jensen (LJ) medium or Middlebrook agar requires a
minimum of 3–4 weeks to produce results. The radiometric BACTEC
TB-460 system, on the other hand, using an enriched liquid medium
decreased the turnaround time (TAT), but the fact that it relies on
radioactive materials represented an inconvenience for its wider
application especially in low-resource countries.
Due to the TAT required by conventional DST methods several new
approaches have been proposed in the last years for the rapid and
early detection of drug drug-resistant M. tuberculosis (Palomino,
2005). Among these, both phenotypic and genotypic methods have
been introduced. The latter look for genetic determinants of resistance
rather than the resistance phenotype involving nucleic acid ampliﬁca-
tion to detect gene mutations known to be associated with drug-
resistance, while phenotypic methods are based on detection of
growth in the presence or absence of antibiotics (Garcia de Viedma,
2003; Palomino, 2006). The costs involved in setting up genotypic
methods and their requirement for skilled personnel have precluded
their wider implementation in clinical mycobacteriology laboratories,
especially in low-resource countries where the TB situation and the
problem of drug-resistance are of major concern. Phenotypic methods
are receiving renewed attention since in general they are simple to
perform, allow for several drugs being tested simultaneously, and in
principle they are applicable to all drugs. This review will address
phenotypic culture-based methods for the rapid detection of drug-
resistance in M. tuberculosis.
2. Liquid culture-based methods
Several liquid culture-based methods for cultivation and DST ofM.
tuberculosis have been introduced during the last years. Most of them
are commercially available and rely on the fact that faster growth isPlease cite this article as: Palomino, J.C., et al., Rapid culture-based met
Microbiol. Methods (2008), doi:10.1016/j.mimet.2008.06.015usually obtained in liquid medium. Some of them are simple manual
methods while others rely on more sophisticated automated systems.
Recent recommendations by the WHO encourage the use of liquid
culture media for cultivation and DST of M. tuberculosis in low- and
middle-income settings (World Health Organization, 2007b).
2.1. The Mycobacteria Growth Indicator Tube (MGIT)
The MGIT manual system (Becton Dickinson, Sparks, MD) was one
of the ﬁrst commercial liquid systems introduced for the rapid
detection of mycobacterial growth. It is based on a ﬂuorescence
quenching-based oxygen sensor embedded at the bottom of the tube
containing an enriched Middlebrook 7H9 broth. Consumption of the
dissolved oxygen by the growing mycobacteria produces an orange
ﬂuorescence when illuminated with an UV lamp (Palomino, 2000).
The MGIT manual system was subsequently applied for rapid DST of
M. tuberculosis. For this purpose, a set of tubes composed of a growth
control and drug-containing tubes are inoculated with the M.
tuberculosis isolate and incubated at 37 °C. Growth is detected by
comparing the ﬂuorescence in the drug-containing tubes and growth
control allowing determination of susceptibility or resistance. Several
studies have evaluated the MGIT manual system for DST of M.
tuberculosis against the ﬁrst-line drugs INH, RIF, ethambutol (EMB)
and streptomycin (SM) with good results (Reisner et al., 1995; Palaci
et al., 1996; Palomino et al., 1999). These studies found good accuracy
for detecting resistance, especially for INH and RIF. There are very few
published studies evaluating the manual MGIT method for DST of a
second-line drug (Bastian et al., 2001; Martin et al., 2005a,b). It has
performed, however, very well for kanamycin and oﬂoxacin, showing
that although not frequently used, it could represent a simple and
reliable method for DST to second-line anti-tuberculosis drugs. Very
few studies also exist evaluating the manual MGIT directly in sputum
samples (Goloubeva et al., 2001; El-Sayed Zaki and Goda, 2007). These
studies have applied manual MGIT on smear-positive sputum samples
and results have been obtained on an average of 5–8 days with
accuracy above 90% for detecting resistance to RIF and INH. The
manual MGIT, thus, remains an interesting option for the rapid
detection of drug-resistant M. tuberculosis with the possibility to be
applied directly on sputum samples.
2.2. The BACTEC MGIT960 automated system
Soon after the MGIT manual system was developed and tested for
diagnosis and DST ofM. tuberculosis an automated system based on the
same principle was proposed. The BACTEC MGIT960 system (Becton
Dickinson, Sparks, MD) performs incubation and reading of the tubes
continuously inside the machine using a predeﬁned algorithm to
interpret the ﬂuorescent signal and giving the results as positive or
negative (Tortoli et al., 1999). When performing DST, the BACTEC
MGIT960 interprets the results as susceptible or resistant to the
antibiotic under study. Results are available within 8 days (Ardito et
al., 2001). Many studies have been performed for evaluating the BACTEC
MGIT960 system for DSTofM. tuberculosis (Tortoli et al., 2002; Johansen
et al., 2004; Scarparo et al., 2004). A recent meta-analysis of the
published studies found high accuracy and high predictive values
associated with the use of BACTEC MGIT960 (Piersimoni et al., 2006).
Also, amulticentre validation has beenperformed to test susceptibilities
ofM. tuberculosis to classical second-line drugs giving accurate results as
compared to the BACTEC TB-460 radiometric method (Rusch-Gerdes et
al., 2006). The BACTECMGIT960 system is now practically replacing the
radiometric BACTEC TB-460 as a rapid and reliablemethod for diagnosis
and DST of M. tuberculosis. The investment required for obtaining the
equipment and its large capacity for workload may limit, however, its
adoption by small- andmedium-sized diagnostic laboratories especially
in high-burden low-resource countries. Efforts to address this issue are
currently under development (FIND, 2008).hods for drug-resistance detection in Mycobacterium tuberculosis, J.
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Formerly known as the MB/BacT system (bioMerieux, Durham, N.C.)
it is an automated commercial liquid culture-based system originally
developed for blood cultures and later applied for diagnosis and DST of
M. tuberculosis. The system uses amodiﬁed 7H9Middlebrook broth and
incorporates a colorimetric sensor at the bottom of the vial that
measures changes in CO2 production by themetabolizingmycobacteria.
A change in colour fromgreen to yellow indicates a positive reaction and
each vial is continuously monitored inside the apparatus (Rohner et al.,
1997). Several studies have evaluated the BacT/Alert 3D system for rapid
DSTofM. tuberculosis toﬁrst-line drugs includingpyrazinamide (Ängeby
et al., 2003; Bemer et al., 2004; Brunello and Fontana, 2000). Although
using different critical concentrations and timing for reading of results
the BacT/Alert 3D system has also shown good sensitivity and
speciﬁcity; however, further evaluations would be desirable to fully
assess the usefulness of this system for rapid DSTofM. tuberculosis. Also,
no studies have been published yet for DST to second-line drugs.
2.4. The Versa TREK system
It was formerly known as the ESP culture system II (Trek Diagnostic
systems, West Lake, OH). Also based on an automated format
originally developed for blood culture and later applied for detection
and DST ofM. tuberculosis, it uses an enriched 7H9 Middlebrook broth
for detection of growth by measuring pressure changes inside the
culture vial due to mycobacterial metabolism. Incubation and reading
is accomplished inside the same apparatus (Woods et al., 1997). Fewer
studies have evaluated the Versa TREK system for DST of M.
tuberculosis against ﬁrst-line drugs (Bergmann and Woods, 1998;
Ruiz et al., 2000; LaBombardi, 2002). Moreover, one of these studies
reported a high proportion of discordant results for INH (Ruiz et al.,
2000). For this reason, further studies are needed to evaluate the real
usefulness of this system for DST of M. tuberculosis.
2.5. The microscopic observation broth-drug susceptibility assay (MODS)
MODS is an ‘in-house’ method based on the observation of the
characteristic cord formation of M. tuberculosis when growing in a
liquid medium (Caviedes et al., 2000). The test was originally
described for detection and DST of M. tuberculosis in sputum
samples. For performance of DST, decontaminated sputum samples
are inoculated into 7H9 liquid medium in 24-well plates with or
without antibiotics and incubated at 37 °C in a CO2 incubator.
Reading of the plates is performed with an inverted microscope at
40× magniﬁcation to identify the typical cord formation of M.
tuberculosis. Growth in the drug-containing wells and in the growth
control is interpreted as resistance. MODS has been evaluated
against ﬁrst-line drugs although better results have been obtained
for RIF and INH (Moore et al., 2004, 2006). Although fairly accurate to
detect resistance, especially to RIF, the requirement of an inverted
microscope to read the plates and biosafety concerns related to the
use of liquid medium in 24-well plates may hamper, however, its
application outside large reference laboratories with the necessary
logistic facilities.
2.6. The colorimetric redox indicator methods
These rapid colorimetric tests rely on the use of a coloured
oxidation–reduction indicator that is added to the culture medium
after M. tuberculosis has grown in the presence or absence of
antibiotics. Reduction of the redox indicator will produce a change
of colour in the medium that is easily interpreted visually. If the
bacteria grow in the presence of the antibiotic as compared to the
growth control it is considered as resistant to this drug. These assays
can be performed in microtiter plates or in culture tubes with resultsPlease cite this article as: Palomino, J.C., et al., Rapid culture-based met
Microbiol. Methods (2008), doi:10.1016/j.mimet.2008.06.015available in 7–8 days. The method allows easily determining the
minimal inhibitory concentrations (MICs) of anti-tuberculosis drugs
(Palomino et al., 2007). Various redox indicators have been proposed,
with Alamar blue (Yajko et al., 1995; Franzblau et al., 1998), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
(Mshana et al., 1998; Foongladda et al., 2002) and resazurin (Palomino
et al., 2002; Banﬁ et al., 2003) giving the most reliable and accurate
results for DST of INH and RIF. The redox indicator resazurin has also
been used to assess DST to second-line drugs (Martin et al., 2003).
Resazurin has also been used in a modiﬁed colorimetric assay to
determine resistance to pyrazinamide using nicotinamide (Martin
et al., 2006). In a multicentre study performed in seven laboratories in
middle- and low-income countries, redox indicator-based assays
performed well with an overall accuracy of 97% for detecting MDR-TB
(Martin et al., 2005a,b). A recent meta-analysis of colorimetric
methods using redox indicators for DST of M. tuberculosis showed
that there is evidence of high sensitivity and speciﬁcity of these
methods (Martin et al., 2007).
2.7. Slide-culture technique
This is an older method recently modiﬁed and evaluated for rapid
detection of MDR-TB in sputum samples (Hamid Salim et al., 2006). It
uses Sula liquid mediumwith added antibiotics to control contamina-
tion. For each sample tested, ten sputum smears are made on one end
of autoclaved slides, cut in half longitudinally, decontaminated with
5% aqueous sulphuric acid for 15 min, washed in water, and placed
individually in sterile glass bottles containing 7 ml of medium. Three
bottles without antibiotics as growth controls, and additional
individual bottles containing medium plus INH at 0.2 and 1 μg/ml;
RIF at 1 μg/ml; EMB at 2, 5, and 10 μg/ml, and SM at 2 μg/ml are also set
up. After overnight refrigeration, all bottles are incubated at 37 °C for
10 days, and heated at 85 °C for 30 min before opening. Dried smears
are heat-ﬁxed, stained by Ziehl–Neelsen and examined at 100×
magniﬁcation for counting acid-fast microcolonies. Any number of
well-developed colonies in the drug-containing bottles with at least
one colony per low-power ﬁeld in the growth control is interpreted as
resistance. When applied on fresh smear-positive sputum samples the
slide-DST technique gave an accuracy of 96% for detecting resistance
to RIF. For INH, however, the accuracy was only 90% and much lower
for EMB and SM. Although simple in its principle and interpretation of
results, this technique follows a cumbersome procedure and requires
the preparation of a large number of slides for each sample making it
less appropriate to analyze several samples at the same time.
Furthermore, there are biosafety concerns, since the same study
found that there were still live M. tuberculosis bacilli able to grow
colonies on LJ medium even after the slides were heated at 85 °C for
30 min previous to microscopical examination.
3. Solid culture-based methods
New alternative methods for rapid DST of M. tuberculosis using
solid culture media have also been recently proposed. The majority of
these alternative procedures have been developed as ‘in-house’
methods with the purpose of shortening the TAT to obtain ﬁnal
results.
3.1. Mycobacteriophage-based methods
Two formats of phage-basedmethods have been proposed as rapid
techniques for drug-resistance detection inM. tuberculosis, the phage-
ampliﬁcation method and the luciferase reporter method. Phage-
ampliﬁcation methods are based on the replication of the phage D29
inside viable mycobacteria while the luciferase reporter method relies
on the production of light by an engineered phage containing the
luciferase gene (Palomino, 2005).hods for drug-resistance detection in Mycobacterium tuberculosis, J.
Table 1
Main culture-based methods for rapid drug-resistance detection of M. tuberculosis
Method Format Antibiotic TATa
(days)
Reference
MGIT
manual
Liquid in tubes RIF b, INH, EMB, SM,
KAN, OFLO
5–8 c 9,18,25,37,48,49,57
MGIT
automated
Liquid in tubes
automated
RIF, INH, EMB, SM,
PZA, AMK, CAP, ETH,
PTH, OFLO, RIB, LIN
5–8 6,30,56,61,62,67
BacT/Alert 3D Liquid in tubes
automated
RIF, INH, EMB, SM,
PZA
6–8 5,11,13,59
Versa TREK Liquid in tubes
automated
RIF, INH, EMB, SM, 4–8 12,33,60,71
MODS Liquid in 24-well
plates
RIF, INH, EMB, SM, 7–9 d 15,43,44
Colorimetric Liquid in 96-well
plates
RIF, INH, EMB, SM,
PZA, KAN, OFLO,
CAP, ETH, PAS
4–8 7,20,21,35,37–
39,52,55,77
Slide-culture Liquid on
microscopic
slides
RIF, INH, EMB, SM 10 26
FASTPlaque Solid in plates RIF 2–3 2,3
In-house
phage-based
method
Solid in plates RIF 2–3 23,40,64
Liquid in
microplate
Luciferase
reporter phage
Liquid in
membranes or
microplate
RIF 2–3 8,47,58
E-test Solid in plates RIF, INH, EMB, SM,
OFLO, CIP
5–10 27,31,68
Nitrate
reductase
Solid in tubes RIF, INH, EMB, SM,
OFLO
7–10 e 4,34,42
Microcolony
(TLA)
Solid in plates RIF, INH, EMB, SM,
PZA
13 63
TK medium Solid in tubes RIF, INH, EMB, SM 7 10
a TAT, turnaround time.
b RIF, rifampicin; INH, isoniazid; EMB, ethambutol; SM, streptomycin; KAN,
kanamycin; OFLO, oﬂoxacin; PZA, pyrazinamide: AMK, amikacin; CAP, capreomycin;
ETH, ethionamide; PTH, prothionamide; RIB, rifabutin; LIN, linezolid; PAS, para-amino
salicylic acid.
c 6–9 days when performed directly in sputum samples.
d Performed directly in sputum samples.
e 14–28 days when performed directly in sputum samples.
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This is a commercial system based on the method originally
described by Wilson et al. (1997) for rapid DST of M. tuberculosis
(Wilson et al., 1997). The FASTPlaque-Response (Biotec, Ipswich, UK) is
a phage-based assay to detect resistance to RIF in smear-positive
sputum samples. According to the recommended procedure, decon-
taminated sputum samples are incubated in the presence or absence
of RIF and thenwith a suspension of the phages. After a period of time
to allow infection of M. tuberculosis, the extracellular phages
remaining are removed with a virucidal solution and the replicating
phages are detected as plaques of lysis when plated with an indicator
non-pathogenic mycobacterium such as M. smegmatis. Results are
read visually within 2 days. The presence of viableM. tuberculosis after
incubation with RIF is interpreted as resistance to this drug. Several
studies have evaluated the FASTPlaque assay as well as modiﬁcations
of the ‘in-house’ phage method with variable results (Albert et al.,
2001, 2004; Galí et al., 2003; Simboli et al., 2005; McNerney et al.,
2007). In a recent meta-analysis six evaluation studies were
considered, all looking at resistance to RIF. A sensitivity of 97–100%
and speciﬁcity of 84–100% was reported (Pai et al., 2005). However,
very few studies have been done with other antibiotics.
3.3. Luciferase reporter phages
Tests based on luciferase reporter phages have been less evaluated.
They rely on infection of M. tuberculosis with phages harbouring the
luciferase gene. Viablemycobacteriawill allow replication of the phages
and production of light in the presence of cellular ATP and the substrate
luciferin that is added to the medium (Riska et al., 1999). When
incubated in the presence of RIF this production of lightwill be inhibited
in susceptible isolates (Bardarov et al., 2003; Hazbón et al., 2003). Seven
studies were identiﬁed in themeta-analysis mentioned above reporting
sensitivityof 100%and speciﬁcityof 89–100% (Pai et al., 2005).Due to the
methodology employed and the requirement for engineered phages,
this technique has not gained wide application yet in diagnostic clinical
laboratories, and seemsmore appropriate for research laboratories with
the capacity and technical expertise required for its execution.
3.4. The E-test
Although not developed exclusively forM. tuberculosis the E-test is
a commercial system allowing rapid DST to several antibiotics (Yeung
et al.,1993). It relies onplastic strips that have an impregnated gradient
of the antibiotic allowing reading ofMICs directly at the zone of growth
inhibition when applied on the surface of an agar plate. When testing
M. tuberculosis an inoculum equivalent to 3.0 McFarland was
recommended with results available within 5–10 days (Wanger and
Mills, 1996). More recent evaluations have found a good correlation
with the reference proportion method in agar when testing suscept-
ibility to ﬁrst-line drugs (Joloba et al., 2000; Hazbón et al., 2000).
However, the requirement of a very high inoculum concentration may
represent a disadvantage, especially when dealing with potentially
highly drug-resistant strains such as MDR and XDR M. tuberculosis.
3.5. The nitrate reductase assay
The nitrate reductase assay (NRA) is another simple procedure
recently proposed as a rapid method for DST of M. tuberculosis. It is
based on the capacity of M. tuberculosis to reduce nitrate to nitrite
which is then easily detected in a coloured reaction (Ängeby et al.,
2002). The NRA, also known as the Griess reaction, has been used
before in the panel of biochemical tests for the identiﬁcation of M.
tuberculosis (Kent and Kubica, 1985). The NRA has been evaluated in
recent studies to detect resistance to ﬁrst-line drugs and oﬂoxacin
showing a good concordance with the reference proportion methodPlease cite this article as: Palomino, J.C., et al., Rapid culture-based met
Microbiol. Methods (2008), doi:10.1016/j.mimet.2008.06.015(Martin et al., 2005a,b; Ängeby et al., 2002; Montoro et al., 2005;
Lemus et al., 2006). An interesting possibility of the NRA is its direct
application on sputum samples. This has been accomplished recently
in three different studies performed in middle- and low-income
settings with encouraging results for detecting resistance to RIF and
INH (Musa et al., 2005; Solis et al., 2005; Affolabi et al., 2007).
3.6. The microcolony method
Also known as the thin-layer agar method, on which the MODS
assay described above is based, it is performed on Middlebrook 7H11
agar. It was originally described for the rapid detection of mycobacter-
ial growth and later applied as a rapid DSTmethod (Welch et al., 1993;
Mejia et al., 1999). When tested directly on sputum samples it
detected multidrug-resistance within 13 days in smear-positive
samples and in 38 days in smear-negative samples (Schaberg et al.,
1995). Further studies in target populations are necessary to assess the
feasibility of implementation and accuracy of this method for rapid
detection of drug-resistance in M. tuberculosis.
3.7. The TK medium
This is a commercial system based on solid media containing dye
indicators. The metabolic activity of the mycobacteria will produce a
change in the original colour of the medium (red) that allows
differentiating mycobacterial growth (yellow) from growth of con-
taminants (green) (Baylan et al., 2004). TK INH, TK RIF, TK STR and TK
EMB are individual tubes of the TK medium containing ﬁrst-linehods for drug-resistance detection in Mycobacterium tuberculosis, J.
5J.C. Palomino et al. / Journal of Microbiological Methods xxx (2008) xxx-xxx
ARTICLE IN PRESSantibiotics and presented as a rapid kit to detect resistance to these
drugs. Unfortunately there is only one published study evaluating this
method and with a very small number of isolates (Baylan et al., 2004).
Table 1 shows and overview of the main rapid culture-based
methods for rapid DST of M. tuberculosis.
4. Future perspectives
The search for alternative and faster methods for drug-resistance
detection ofM. tuberculosis is a continuing endeavour due to the long TAT
of conventional methods and the difﬁculties of implementing newer
molecular techniques on a routine basis, especially in low-resource
countrieswhere theburdenofTBanddrug-resistance ismoredemanding.
In this context, several newer culture-based methods have been
proposed and thoroughly evaluated in several settings. Among the
commercially available methods described above, the MGIT system,
both in its manual and automated versions, have shown high
sensitivity and speciﬁcity in detecting resistance to RIF and INH, the
two most important drugs in the treatment of TB. DST to other ﬁrst-
and second-line drugs have also shown good accuracy, although
additional studies are needed for second-line drugs to determine the
optimal critical concentrations to be tested (Rusch-Gerdes et al.,
2006). More studies are also needed to assess the performance of
MGIT for DST of PZA and for performing DST directly on sputum
samples. In spite of this, and taking into account recent recommenda-
tions of the WHO that encourage the use of liquid media for culture
and DST of M. tuberculosis in low- and medium-income settings
(World Health Organization, 2007b), the BACTEC MGIT960 system
represents today the best alternative to replace the old radiometric
BACTEC TB-460 for rapid DST of M. tuberculosis.
Another commercial system, the FastPlaque, seems to be accurate in
detecting resistance to RIF. Almost no studies have been performed with
other drugs. One recent study evaluating the ‘in-house’ version of this
method reported lower accuracy, with sensitivity of 80.4% and speciﬁcity
of 80.8% for INH (Chauca et al., 2007).More studies of the FastPlaque assay
arewarranted indifferent settings toassess its performance and feasibility
of implementation on a routine basis in TB diagnostic laboratories.
Methods based on the early detection of growth such as MODS and
the thin-layer agar that look for microcolonies of M. tuberculosis need
further validations in different settings to conﬁrm previous results of
sensitivityand speciﬁcity to detect resistance to RIFand INH.Application
of these methods to second-line drugs would also be desirable.
Colorimetric methods using redox indicators have demonstrated
accuracy and reliability for rapid detection of MDR M. tuberculosis
(Martin et al., 2007). Good results have also been obtained when
testing for second-line drugs. Although the microtiter format most
commonly used in this method seems more appropriate for reference
laboratories with the necessary biosafety facilities, the possibility to
implement a macromethod in screw-cap tubes using one critical
concentration of the drug (Coban et al., 2006) makes it more feasible
for implementation in small clinical diagnostic laboratories. Using one
critical concentration of RIF or INH has shown to be enough to obtain
97% accuracy in a previous study with Alamar blue for detection of
drug-resistance (Palomino and Portaels, 1999).
The NRA also appears as a simplemethod for DSTofM. tuberculosis.
One additional advantage of this method is that it uses the same
culturemedium and tube format commonly employed inTB diagnostic
laboratories, facilitating in this way its implementation without the
need for additional equipment or laboratory supplies. It seems also
appropriate as a direct method to be used on sputum samples.
Aswehave described there are newoptions available for rapidDSTof
M. tuberculosis based on culture techniques. Several have proved already
their reliability and accuracy in detecting drug-resistance as compared
to the current methods considered as reference standard. Other
methods need more evaluation to prove their accuracy and reproduci-
bility. One important consideration to take into account should be thePlease cite this article as: Palomino, J.C., et al., Rapid culture-based met
Microbiol. Methods (2008), doi:10.1016/j.mimet.2008.06.015feasibility of implementation of the new method whether it is of a
commercial nature or not, if it is to be used for drug-resistance
surveillance or for rapid drug-resistance detection, and the capabilities
of the laboratory to adapt their routine work to the new techniques.
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